HER2 Antibodies Market to Reach US$ 15.10 Billion by 2034 at a CAGR of 4.80%
The global HER2 antibodies industry continues to gain momentum as targeted cancer therapies become an integral part of modern oncology treatment. Increasing adoption of precision medicine, continuous innovation in biologics, and expanding research activities are strengthening the competitive landscape across … Read more